blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3768274

EP3768274 - COMPOSITION COMPRISING A COMBINATION OF GLYCOCHOLIC ACID AND BUTYRIC ACID OR OLEIC ACID FOR USE IN THE TREATMENT OF OSTEOPOROSIS [Right-click to bookmark this link]
Former [2021/04]A COMPOSITION FOR USE IN THE TREATMENT OF CONDITIONS CAUSED BY CALCIUM DEFICIENCY
[2023/35]
StatusNo opposition filed within time limit
Status updated on  19.09.2024
Database last updated on 02.11.2024
FormerThe patent has been granted
Status updated on  13.10.2023
FormerGrant of patent is intended
Status updated on  08.08.2023
FormerRequest for examination was made
Status updated on  25.12.2020
FormerThe international publication has been made
Status updated on  28.09.2019
Most recent event   Tooltip19.09.2024No opposition filed within time limitpublished on 23.10.2024  [2024/43]
Applicant(s)For all designated states
Epicyt Pharma AB
Box 11072
40422 Göteborg / SE
[2021/04]
Inventor(s)01 / FÄNDRIKS, Lars
Askims Ängsväg 14
236 40 ASKIM / SE
02 / WALLENIUS, Ville
Västra Eklanda Höjd 50
431 59 MÖLNDAL / SE
 [2021/04]
Representative(s)AWA Sweden AB
Box 5117
200 71 Malmö / SE
[2023/46]
Former [2021/04]AWA Sweden AB
P.O. Box 5117
200 71 Malmö / SE
Application number, filing date19770322.619.03.2019
[2021/04]
WO2019SE50246
Priority number, dateSE2018005030419.03.2018         Original published format: SE 1850304
[2021/04]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019182501
Date:26.09.2019
Language:EN
[2019/39]
Type: A1 Application with search report 
No.:EP3768274
Date:27.01.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 26.09.2019 takes the place of the publication of the European patent application.
[2021/04]
Type: B1 Patent specification 
No.:EP3768274
Date:15.11.2023
Language:EN
[2023/46]
Search report(s)International search report - published on:SE26.09.2019
(Supplementary) European search report - dispatched on:EP03.12.2021
ClassificationIPC:A61K31/567, A61K31/19, A61K31/593, A61K33/06, A61P19/00, A61K31/201, A61K31/575, A61K31/592, A61K45/06
[2022/01]
CPC:
A61K31/19 (EP); A61K33/06 (EP,US); A23L33/155 (US);
A23L33/16 (US); A61K31/201 (EP,US); A61K31/575 (EP);
A61K31/592 (EP,US); A61K45/06 (EP); A61P19/00 (EP);
A61K9/0019 (US); A61K9/0053 (US) (-)
C-Set:
A61K31/19, A61K2300/00 (EP);
A61K31/201, A61K2300/00 (EP);
A61K31/575, A61K2300/00 (EP);
A61K31/592, A61K2300/00 (EP);
A61K33/06, A61K2300/00 (EP)
(-)
Former IPC [2021/04]A61K31/567, A61K31/19, A61K31/593, A61K33/06, A61P19/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/04]  
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:ZUSAMMENSETZUNG ENTHALTEND EINE KOMBINATION AUS GLYCOCHOLSÄURE UND BUTTERSÄURE ODER ÖLSÄURE, ZUR VERWENDUNG BEI DER BEHANDLUNG VON OSTEOPOROSE[2023/35]
English:COMPOSITION COMPRISING A COMBINATION OF GLYCOCHOLIC ACID AND BUTYRIC ACID OR OLEIC ACID FOR USE IN THE TREATMENT OF OSTEOPOROSIS[2023/35]
French:COMPOSITION COMPRENANT UNE COMBINAISON D'ACIDE GLYCOCHOLIQUE ET D'ACIDE BUTYRIQUE OU D'ACIDE OLÉIQUE POUR LE TRAITEMENT DE L'OSTÉOPOROSE[2023/35]
Former [2021/04]ZUSAMMENSETZUNG ZUR VERWENDUNG BEI DER BEHANDLUNG VON DURCH CALCIUMMANGEL VERURSACHTEN ERKRANKUNGEN
Former [2021/04]A COMPOSITION FOR USE IN THE TREATMENT OF CONDITIONS CAUSED BY CALCIUM DEFICIENCY
Former [2021/04]COMPOSITION DESTINÉE À ÊTRE UTILISÉE DANS LE TRAITEMENT D'ÉTATS PROVOQUÉS PAR UNE DÉFICIENCE EN CALCIUM
Entry into regional phase12.10.2020National basic fee paid 
12.10.2020Search fee paid 
12.10.2020Designation fee(s) paid 
12.10.2020Examination fee paid 
Examination procedure12.10.2020Examination requested  [2021/04]
22.06.2022Amendment by applicant (claims and/or description)
09.08.2023Communication of intention to grant the patent
10.10.2023Fee for grant paid
10.10.2023Fee for publishing/printing paid
10.10.2023Receipt of the translation of the claim(s)
Opposition(s)19.08.2024No opposition filed within time limit [2024/43]
Fees paidRenewal fee
16.03.2021Renewal fee patent year 03
28.02.2022Renewal fee patent year 04
28.02.2023Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCZ15.11.2023
HR15.11.2023
RO15.11.2023
RS15.11.2023
SK15.11.2023
SM15.11.2023
GR16.02.2024
IS15.03.2024
[2024/36]
Former [2024/35]CZ15.11.2023
HR15.11.2023
RO15.11.2023
RS15.11.2023
SM15.11.2023
GR16.02.2024
IS15.03.2024
Former [2024/33]HR15.11.2023
RS15.11.2023
SM15.11.2023
GR16.02.2024
IS15.03.2024
Former [2024/25]HR15.11.2023
RS15.11.2023
GR16.02.2024
IS15.03.2024
Former [2024/20]GR16.02.2024
IS15.03.2024
Documents cited:Search[XYI]EP0252004  (CIBA GEIGY AG [CH]);
 [XYI]US5376646  (PITTROF FOLKER [US], et al);
 [XYI]EP1270007  (CHIESI FARMA SPA [IT]);
 [XYI]US2014030352  (KHOPADE AJAY JAYSINGH [IN], et al);
International search[A]US2006052305  (QUAY STEVEN C [US], et al);
 [Y]US2007292493  (BRIERRE BARBARA T [US]);
 [A]US2010204191  (MAKISHIMA MAKOTO [JP], et al);
by applicantEP0252004
 US5376646
 EP1270007
 WO2013049595
 US8563053
 US2014030352
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.